AE37 currently has nothing to do w the success Key
Post# of 36537
(Total Views: 313)
Posted On: 10/31/2019 11:03:18 AM
AE37 currently has nothing to do w the success Keytruda is having. It is in Phase II trial to prove that a Keytruda/AE37 combo is better than Keytruda alone. Hopefully MRK sees enough potential for it to throw some $ at the NGIO spin while they wait for the results...
==========
This is what I don't understand as well. If AE37 is working alongside and helps, isn't it part of the success that Keytruda is having or is it just in a trial phase of another aspect of Keytruda they are doing and has no bearing on the overall Keytruda of Merck?
==========
This is what I don't understand as well. If AE37 is working alongside and helps, isn't it part of the success that Keytruda is having or is it just in a trial phase of another aspect of Keytruda they are doing and has no bearing on the overall Keytruda of Merck?
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼